Patterns of NSAIDs use and their association with other analgesic use in CKD
JournalClinical Journal of the American Society of Nephrology
PublisherAmerican Society of Nephrology
MetadataShow full item record
AbstractBackground and objectives Avoiding nonsteroidal anti-inflammatory drugs is important for safe CKD care. This study examined nonsteroidal anti-inflammatory drug use patterns and their association with other analgesic use in CKD. Design, setting, participants, & measurements The Chronic Renal Insufficiency Cohort Study is an observational cohort study that enrolled 3939 adults ages 21-74 years old with CKD between 2003 and 2008 using age-based eGFR inclusion criteria. Annual visits between June of 2003 and December of 2011 were organized into 15,917 visit-pairs (with an antecedent and subsequent visit) for 3872 participants with medication information. Demographics, kidney function, and clinical factors were ascertained along with report of nonsteroidal anti-inflammatory drug or other analgesic use in the prior 30 days. Results In our study, 24% of participants reported nonsteroidal anti-inflammatory drug use at baseline or at least one follow-up study visit. Having a 10 ml/min per 1.73 m 2 higher eGFR level at an antecedent visit was associated with higher odds of starting nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 1.44; 95% confidence interval, 1.34 to 1.56). Seeing a nephrologist at the antecedent visit was associated with lower odds of starting or staying on nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 0.70; 95% confidence interval, 0.56 to 0.87 and odds ratio, 0.61; 95% confidence interval, 0.46 to 0.81, respectively). Starting and stopping nonsteroidal anti-inflammatory drugs were both associated with higher odds of increasing the number of other analgesics (odds ratio, 1.52; 95% confidence interval, 1.25 to 1.85 and odds ratio, 1.78; 95% confidence interval, 1.39 to 2.28, respectively) and higher odds of increasing the number of opioid analgesics specifically (odds ratio, 1.92; 95% confidence interval, 1.48 to 2.48 and odds ratio, 1.46; 95% confidence interval, 1.04 to 2.03, respectively). Conclusions Nonsteroidal anti-inflammatory drug use is common among patients with CKD but less so among those with worse kidney function or those who see a nephrologist. Initiation or discontinuation of nonsteroidal anti-inflammatory drugs is often associated with supplementation with or replacement by, respectively, other analgesics, including opioids, which introduces possible drug-related problems when taking these alternative analgesics. Copyright 2017 by the American Society of Nephrology.
SponsorsFunding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the NIDDK (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85033396296&doi=10.2215%2fCJN.12311216&partnerID=40&md5=7e085e9074bef8573ceaff1df31f07b3; http://hdl.handle.net/10713/10124
- Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
- Authors: Zhan M, Doerfler RM, Xie D, Chen J, Chen HY, Diamantidis CJ, Rahman M, Ricardo AC, Sondheimer J, Strauss L, Wagner LA, Weir MR, Fink JC, CRIC Study Investigators.
- Issue date: 2020 Aug
- Chronic pain and analgesic use in CKD: implications for patient safety.
- Authors: Wu J, Ginsberg JS, Zhan M, Diamantidis CJ, Chen J, Woods C, Fink JC
- Issue date: 2015 Mar 6
- Assessment of Prescription Analgesic Use in Older Adults With and Without Chronic Kidney Disease and Outcomes.
- Authors: Han Y, Balkrishnan R, Hirth RA, Hutton DW, He K, Steffick DE, Saran R
- Issue date: 2020 Sep 1
- Transient renal impairment in the absence of pre-existing chronic kidney disease in patients with unilateral ureteric stone impaction.
- Authors: Kim HY, Choe HS, Lee DS, Yoo JM, Lee SJ
- Issue date: 2017 Jun
- Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
- Authors: Rasu RS, Vouthy K, Crowl AN, Stegeman AE, Fikru B, Bawa WA, Knell ME
- Issue date: 2014 Sep